Don’t see what you’re looking for? Use the search box on MDA’s Quest magazine.
The FDA has approved Nuedexta, a medication that treats uncontrolled expression of emotion related to amyotrophic lateral sclerosis
Posted on Monday, November 1, 2010 - 16:09, By: Margaret Wahl
The U.S. Food and Drug Administration (FDA) has approved Nuedexta for "pseudobulbar affect" (PBA), a neurologic condition that sometimes occurs in people with amyotrophic lateral sclerosis (ALS) and involves episodes of involuntary emotional expression out of proportion to or distinct from the...